FrancophonIA/ELRC3.0 huggingface dataset:
English: Exploratory subgroup analyses for disease-free survival for patients who meet the 2009 St. Gallen chemotherapy criteria - (ITT population) were performed and presented here below:
Danish: Der blev udført eksplorativ undergruppeanalyse af sygdomsfri overlevelse for patienter, der opfylder kriterierne for kemoterapi ifølge 2009 St. Gallen-kriterierne - (ITT population).
English: A hazard ratio of less than 1 favours docetaxel + cisplatin + fluorouracil * Un-adjusted log-rank test ** Un-adjusted log-rank test, not adjusted for multiple comparisons *** Chi-square test, not adjusted for multiple comparisons NA-not applicable
Danish: Med en hazard ratio under 1 kan docetaxel + cisplatin+fluoruracil anvendes med fordel * Ujusteret log-rank test ** Ujusteret log-rank test, ikke justeret efter multipel sammenligning *** Chi-square-test, ikke justeret for multipel sammenligning NA: Ikke relevant (Not Applicable)
English: The length of a treatment cycle was 3 weeks for the TCF arm and 4 weeks for the CF arm.
Danish: uger for TCF-armen og 4 uger for CF-armen.
English: • 1,312 and 121 patients who received 100 mg/m² and 75 mg/m² of docetaxel as a single agent respectively.
Danish: • 1.312 og 121 patienter, som fik henholdsvis 100 mg/m2 og 75 mg/m2 docetaxel som enkeltstof.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 26 January 2010
Danish: Dato for første markedsføringstilladelse: 26. januar 2010 Dato for seneste fornyelse: 14 juli 2014
English: Disseminated intravascular coagulation (DIC), often in association with sepsis or multi-organ failure, has been reported.
Danish: Der er rapporter om dissemineret intravaskulær koagulation (DIC), ofte i forbindelse med sepsis eller multiorgansvigt.
English: The amount of alcohol in this medicinal product may alter the effects of other medicines.
Danish: Mængden af alkohol i dette lægemiddel kan ændre virkningen af anden medicin.
English: In the docetaxel plus trastuzumab arm, 64% had received a prior anthracycline as adjuvant therapy compared with 55% in the docetaxel arm alone.
Danish: I docetaxel - plus trastuzumabarmen, havde 64 % modtaget en tidligere behandling med antracyklin som adjuverende behandling sammenlignet med 55 % i docetaxel-armen alene.
English: When combined to docetaxel, the clearance of carboplatin was about 50% higher than values previously reported for carboplatin monotherapy.
Danish: Ved kombination med docetaxel, var carboplatins clearance af carboplatin ca. 50 % højere end de værdier, der tidligere er rapporteret for carboplatinmonoterapi.
English: Polysorbate 80
Danish: Koncentrat i hætteglas Polysorbat 80
English: Tumour response rate (%) 95% CI p-value* †Stratified log rank test *Threshold for statistical significance=0.0175 **PSA: Prostate-Specific Antigen
Danish: Tumor-responsrate (%) 95 % CI p-værdi* †Stratificeret log rank test *Tærskel for statistisk signifikans =0,0175 **PSA: Prostata-Specific Antigen
English: Patients who experience Grade 3 or 4 stomatitis should have their dose decreased to 60 mg/m².
Danish: Patienter, som får Grad 3- eller 4-stomatitis, bør have deres dosis reduceret til 60 mg/m2.
English: Docetaxel Teva has been prescribed by your doctor for the treatment of breast cancer, special forms of lung cancer (non-small cell lung cancer), prostate cancer, gastric cancer or head and neck cancer: - For the treatment of advanced breast cancer, Docetaxel Teva could be administered either alone or in combination with doxorubicin, or trastuzumab, or capecitabine.
Danish: Docetaxel Teva er ordineret af din læge til behandling af brystkræft, specielle former for lungekræft (ikke-småcellet lungekræft), prostatakræft, gastrisk kræft eller hoved- og halskræft: - Ved behandling af fremskreden brystkræft kan Docetaxel Teva enten indgives alene eller i kombination med doxorubicin, eller trastuzumab eller capecitabin.
English: Although the possible in vivo interaction of docetaxel with concomitantly administered medicinal product has not been investigated formally, in vitro interactions with tightly protein-bound agents such as erythromycin, diphenhydramine, propranolol, propafenone, phenytoin, salicylate, sulfamethoxazole and sodium valproate did not affect protein binding of docetaxel.
Danish: Skønt mulige in vivo-interaktioner mellem docetaxel og andre samtidigt administrerede lægemidler ikke er undersøgt formelt, har in vitrointeraktioner med kraftigt proteinbundne stoffer såsom erythromycin, diphenhydramin, propranolol, propafenon, phenytoin, salicylat, sulfamethoxazol og natriumvalproat, ikke påvirket docetaxels proteinbinding.
English: The median TTP was 37.3 weeks (95% CI:33.4 - 42.1) in AT arm and 31.9 weeks (95% CI: 27.4 - 36.0) in AC arm.
Danish: TTP-medianen var 37,3 uger (95 % CI: 33,4 - 42,1) i AT-armen og 31,9 uger (95 % CI: 27,4 - 36,0) i AC-armen.
English: Myalgia (severe: 1.4%) Arthralgia
Danish: Myalgi (alvorlig 1,4 %) Artralgi
English: In this study, 87% of patients had disease that was IHC 3+, and 95% of patients entered had disease that was IHC 3+ and/or FISH positive.
Danish: I dette studie havde 87 % af patienterne sygdom, som var IHC 3+, og 95 % af de inkluderede patienter havde sygdom, som var IHC3+ og/eller patienterne var FISH-positive.
English: The name of this medicine is Docetaxel Teva.
Danish: Medicinen hedder Docetaxel Teva.
English: • 1,276 patients (744 and 532 in TAX 316 and GEICAM 9805 respectively) who received docetaxel in combination with doxorubicin and cyclophosphamide (clinically important treatment related adverse events are presented).
Danish: • 1.276 patienter (744 i TAX 316 og 532 i GEICAM 9805), som fik docetaxel i kombination med doxorubicin og cyclofosfamid (bivirkninger til klinisk vigtig behandling er præsenteret).
English: FAC arm), as adjuvant treatment of operable node-negative breast cancer patients with high risk of relapse according to 1998 St. Gallen criteria (tumour size >2 cm and/or negative ER and PR and/or high histological/nuclear grade (grade 2 to 3) and /or age <35 years).
Danish: lymfeknude-negativ brystkræft med høj risiko for tilbagefald ifølge 1998 St. Gallen-kriterierne (tumorstørrelse > 2 cm og/eller negative østrogenreceptorer (ER) og progesteronreceptorer (PR) og/eller høj histologisk/nukleær grad (grad 2 til 3) og/eller alder < 35 år).
English: The adverse reactions considered to be possibly or probably related to the administration of docetaxel have been obtained in:
Danish: De bivirkninger, som sandsynligvis er relateret til anvendelsen af docetaxel, er set hos:
English: The median number of cycles administered per patient was 6 (with a range of 1-16) for the TCF arm compared to 4 (with a range of 1-12) for the CF arm. Time to progression (TTP) was the primary endpoint.
Danish: Median-antallet af cyklusser administreret pr. patient var 6 (med et interval på 1-16) for TCF-armen sammenlignet med 4 (med et interval på 1-12) for CF-armen.
English: Discuss with your doctor if you suffer from alcohol dependency, epilepsy or liver impairment.
Danish: Tal med din læge, hvis du er afhængig af alkohol, lider af epilesi, eller hvis din leverfunktion er nedsat.
English: Neutropenia (G3/4: 32%); Febrile neutropenia (includes neutropenia associated with fever and antibiotic use) or neutropenic sepsis
Danish: Neutropeni (G3/4: 32 %); Febril neutropeni (inklusive neutropeni associeret med feber og brug af antibiotika) eller neutropenisk sepsis
English: In vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds which induce, inhibit or are metabolised by (and thus may inhibit the enzyme competitively) cytochrome P450-3A such as ciclosporine, ketoconazole and erythromycin.
Danish: In vitro-studier har vist, at docetaxels metabolisme kan ændres ved samtidig medicinering med stoffer, som inducerer, hæmmer eller metaboliseres (og således hæmmer enzymet kompetitivt) af cytochrom P450 3A, f.eks. ciclosporin, ketokonazol og erythromycin.
English: Deutschland Teva GmbH Tel: +49 731 402 08
Danish: Teva GmbH Tel: +49 731 402 08
English: Following the administration of a 100 mg/m2 dose given as a one hour infusion a mean peak plasma level of 3.7 μg/ml was obtained with a corresponding AUC of 4.6 h.μg/ml.
Danish: Efter administration af docetaxel 100 mg/m2 givet som infusion over 1 time, fandtes den gennemsnitlige maksimale plasmakoncentration at være 3,7 mg/ml med et AUC på 4,6 h.μg/ml.
English: MARKETING AUTHORISATION NUMBER EU/1/09/611/002
Danish: EU/1/09/611/002
English: The survival rate was 93.7% in the TAC arm and 91.4% in the FAC arm, at the 8-year follow-up time point, and 91.3% in the TAC arm and 89% in the FAC arm, at the 10-year follow-up time point.
Danish: Overlevelsesprocenten var 93,7 % i TAC-armen og 91,4 % i FAC-armen ved tidspunktet for 8-års followup, og 91,3 % i TAC-armen og 89 % i FAC-armen ved tidspunktet for 10-års followup.
English: The second interim analysis was done after 400 DFS events had been recorded overall, which led to a median follow-up of 55 months.
Danish: Den anden interim-analyse blev udført efter optagelse af i alt 400 sygdoms-fri overlevelser (DFS), hvilket førte til en medianopfølgningstid på 55 måneder.
English: Time to progressive disease was superior in the docetaxel + capecitabine combination arm (p<0.0001).
Danish: Tid indtil progressiv sygdom var længere i kombinationsarmen med docetaxel + docetaxel (p < 0,0001).
English: 256 patients were randomised to treatment with docetaxel alone (100 mg/ m2 as a 1 hour intravenous infusion every 3 weeks).
Danish: 256 patienter blev randomiseret til behandling med docetaxel alene (100 mg/m2 som 1 times intravenøs infusion hver 3. uge).
English: • feeling of numbness or pins and needles or pain in the joints or muscles
Danish: • Følelsesløshed eller stikkende og prikkende fornemmelse eller smerter i led eller muskler
English: For any information about this medicinal product, please contact the local representative of the Marketing Authorisation Holder:
Danish: Hvis du vil have yderligere oplysninger om Docetaxel Teva, skal du henvende dig til den lokale repræsentant for indehaveren af markedsføringstilladelsen:
English: A hazard ratio of less than 1 favours docetaxel + cisplatin + 5-FU *Cox model (adjustment for Primary tumour site, T and N clinical stages and PSWHO) **Log rank test *** Chi-square test
Danish: Med en hazard ratio < 1 kan docetaxel + cisplatin+5-FU anvendes med fordel *Cox model (tilpasning til primær tumor, T og N kliniske stadier og PSWHO) **Logrank test *** Chi-square-test
English: In vivo, docetaxel is schedule independent and has a broad spectrum of experimental anti-tumour activity against advanced murine and human grafted tumours.
Danish: In vivo er docetaxels aktivitet uafhængig af behandlingsregimet og har eksperimentelt vist et bredt spektrum af antitumoraktivitet over for fremskredne murine og transplanterede humane tumorer.
English: • operable node-positive breast cancer • operable node-negative breast cancer
Danish: • operabel lymfeknude-positiv brystkræft • operabel, lymfeknude-negativ brystkræft
English: Docetaxel plus trastuzumab was efficacious in patients whether or not they had received prior adjuvant anthracyclines.
Danish: Docetaxel + trastuzumab var effektivt til patienterne, uanset om de havde fået adjuverende anthracyklin eller ikke.
English: Docetaxel Teva contains ethanol (alcohol)
Danish: Docetaxel Teva indeholder ethanol (alkohol)
English: Preparation for the intravenous administration a) Preparation of the Docetaxel Teva premix solution (10 mg docetaxel/ml)
Danish: Tilberedning til intravenøs administration a) Tilberedning af Docetaxel Teva præmix (10 mg docetaxel/ml)
English: The performance status scale, for head and neck (PSS-HN) subscales designed to measure understandability of speech, ability to eat in public, and normalcy of diet, was significantly in favour of TPF as compared to PF.
Danish: Statusskalaen for hoved- og hals-underskalaer (PSS-HN) var designet til at måle sprogforståelse, evnen til at indtage føde offentligt samt en normal kost.
English: very common (≥1/10), common (≥1/100 to < 1/10); uncommon (≥1/1,000 to < 1/100); rare (≥1/10,000
Danish: Hyppigheder defineres som: meget almindelig (≥ 1/10); almindelig (≥ 1/100 til < 1/10); ikke almindelig (≥ 1/1000 til
English: Subset Analyses-Adjuvant Therapy in Patients with Node-negative Breast Cancer Study (Intent-toTreat Analysis)
Danish: Undergruppeanalyser - adjuverende behandling hos patienter med lymfeknude-negativ brystkræft (intent-to-treat analyse)
English: • 174 and 251 head and neck cancer patients who received docetaxel in combination with cisplatin and 5-fluorouracil (clinically important treatment related adverse events are presented).
Danish: • 174 og 251 hoved- og halskræftpatienter, som blev behandlet med docetaxel i kombination med cisplatin og 5-fluoruracil (klinisk vigtige behandlingsrelaterede bivirkninger er nævnt).
English: The most commonly reported adverse reactions of Docetaxel Teva alone are: decrease in the number of red blood cells or white blood cells, alopecia, nausea, vomiting, sores in the mouth, diarrhoea and tiredness.
Danish: De mest almindelige bivirkninger ved Docetaxel Teva givet alene er: Fald i antallet af røde og hvide blodlegemer, hårtab, kvalme, opkastning, sår i munden, diarré og træthed.
English: Data from a multi-centre open-label randomised study support the use of docetaxel for the adjuvant treatment of patients with operable node-positive breast cancer and KPS ≥ 80%, between 18 and 70 years of age.
Danish: Data fra et multicenter åbent randomiseret studium støtter anvendelsen af den adjuverende behandling til patienter med operabel lymfeknude-positiv brystkræft og KPS ≥ 80 % i alderen mellem 18 og 70 år.
English: Additional cautions for use in adjuvant treatment of breast cancer
Danish: Yderligere forsigtighedsregler for anvendelse ved adjuverende behandling af brystkræft Kompliceret neutropeni
English: Mean values for total body clearance and steady-state volume of distribution were 21 l/h/m2 and 113 l, respectively.
Danish: Gennemsnitsværdierne for den totale clearance og steady-state distributionsvolumen var henholdsvis 21 l/h/m2 og 113 l. Den interindividuelle variation i totalclearance var ca. 50 %.
English: During the infusion at the hospital the following allergic reactions may occur (may affect more than 1 in 10 people):
Danish: Følgende allergiske reaktioner kan forekomme (kan forekomme hos flere end 1 ud af 10 patienter)
English: See also section ”Docetaxel Teva contains ethanol (alcohol)” below.
Danish: Se også ” Docetaxel Teva indeholder ethanol (alkohol)” nedenfor.
English: At the end of chemotherapy, with a minimal interval of 4 weeks and a maximal interval of 7 weeks, patients whose disease did not progress received radiotherapy (RT) according to institutional guidelines for 7 weeks (PF/RT).
Danish: Efter endt kemoterapi, med et minimuminterval på 4 uger og et maksimuminterval på 7 uger, blev de patienter, hvis sygdom ikke forværredes, strålebehandlet (RT) i 7 uger i henhold til de fastlagte retningslinjer (PF/RT).
English: There is no relevant use of Docetaxel Teva in the paediatric population in the indications breast cancer, non-small cell lung cancer, prostate cancer, gastric carcinoma and head and neck cancer, not including type II and III less differentiated nasopharyngeal carcinoma.
Danish: Der er ingen relevant anvendelse af Docetacel Teva i den pædiatriske population til indikationerne brystkræft, ikke-småcellet lungekræft, prostatakræft, gastrisk karcinom samt hoved- og halskræft med undtagelse af type II og III lavt differentieret nasofaryngealt karcinom.
English: Median overall survival was also significantly longer in favour of the TPF arm compared to the PF arm (median OS: 18.6 vs. 14.5 months respectively) with a 28% risk reduction of mortality, p = 0.0128.
Danish: Median overlevelse i alt var også signifikant længere til fordel for TPF-armen sammenlignet med PF-armen (median overlevelse i alt: 18,6 vs. 14,5 måneder respektivt) med en 28 % reduktion af risikoen for død, p = 0,0128.
English: • Infusion solution: Chemical and physical in-use stability has been demonstrated for 4 hours at room temperature (below 25°C).
Danish: • Infusionsopløsning: Kemisk og fysisk stabilitet under brug er påvist i 4 timer ved stuetemperatur (under 25 °C).
English: Tél: +33 1 55 91 78 00
Danish: Teva Santé Tél: +33 1 55 91 78 00
English: Infections (G3/4: 5.7%; including sepsis and pneumonia, fatal in
Danish: Infektioner (G3/4: inklusive sepsis og pneumoni, fatal hos
English: • one vial (5.12 ml) of solvent (water for injections).
Danish: • et hætteglas (5,12 ml) med solvens (vand til injektionsvæsker).
English: All patients who did not have progressive disease were to receive chemoradiotherapy (CRT) as per protocol (TPF/CRT).
Danish: Patienter uden forværret sygdom skulle modtage kemostråleterapi (CRT) ifølge protokollen (TPF/CRT).
English: Infections and infestations
Danish: Infektioner og parasitære
English: • inflammation of the colon, small intestine, which could be fatal (frequency not known);
Danish: • Betændelse i tyktarm, tyndtarm, som kan være dødelig (hyppighed ikke kendt); perforering af tarmene.
English: Patients should not be retreated with subsequent cycles of docetaxel until neutrophils recover to a level > 1,500 cells/mm3 and platelets recover to a level > 100,000 cells/mm3.
Danish: Patienter bør ikke genbehandles med efterfølgende cyklusser af docetaxel, indtil neutrofil-antallet gendannes til et niveau > 1.500 celler/mm og blodplader gendannes til et niveau > 100.000 celler/mm3.
English: • Mitoxantrone 12 mg/m2 every 3 weeks for 10 cycles.
Danish: • Mitoxantron 12 mg/m2 hver 3. uge i 10 behandlingsrunder.
English: Neutropenia (G4:
Danish: Neutropeni (G4:
English: Docetaxel Teva in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:
Danish: Docetaxel Teva i kombination med doxorubicin og cyclofosfamid er indiceret til adjuverende behandling af patienter med:
English: • fever or chills
Danish: • feber eller kulderystelser,
English: The primary endpoint in this study, progression-free survival (PFS), was significantly longer in the TPF arm compared to the PF arm, p = 0.0042 (median PFS: 11.4 vs. 8.3 months respectively) with an overall median follow up time of 33.7 months.
Danish: Det primære endepunkt i dette studie, progression-fri overlevelse (PFS), var signifikant længere i TPF-armen sammenlignet med PF-armen, p = 0,0042 (median PFS: 11,4 vs. 8,3 måneder respektivt) med en samlet medianopfølgningstid på 33,7 måneder.
English: The severity of adverse events of Docetaxel Teva may be increased when Docetaxel Teva is given in combination with other chemotherapeutic agents.
Danish: Alvorligheden af bivirkningerne ved Docetaxel Teva kan forøges, når Docetaxel Teva gives i kombination med andre kemoterapeutiske lægemidler.
English: As the benefit observed in patients with 4+ nodes was not statistically significant on DFS and OS, the positive benefit/risk ratio for TAC in patients with 4+ nodes was not fully demonstrated at the final analysis.
Danish: Da fordelene hos patienter med 4+ lymfeknuder ikke var statistisk signifikant for DFS og OS, blev den positive benefit/risk fordeling for TAC hos patienter med 4+ lymfeknuder ikke helt demonstreret ved den endelige analyse.
English: The European Medicines Agency has waived the obligation to submit the results of studies with the reference medicinal product containing docetaxel in all subsets of the paediatric population in breast cancer, non-small cell lung cancer, prostated cancer, gastric carcinoma and head and neck cancer, not including type II and III less differentiated nasopharyngeal carcinoma (see section 4.2 for information on paediatric use).
Danish: Det Europæiske Lægemiddelagentur har dispenseret fra kravet om at fremlægge resultaterne af studier med referencelægemidlet der indeholder docetaxel i alle undergrupper af den pædiatriske population ved brystkræft, ikke-småcellet lungekræft, prostatakræft, gastrisk adenokarcinom og hoved- og halskræft med undtagelse af type II og type III lavt differentieret nasofaryngealt karcinom (se pkt.
English: - For the treatment of early breast cancer with or without lymph node involvement, Docetaxel Teva could be administered in combination with doxorubicin and cyclophosphamide.
Danish: - Ved behandling af tidlig brystkræft med eller uden lymfeknuder, kan Docetaxel Teva anvendes i kombination med doxorubicin eller cyclofosfamid.
English: One large randomised phase III study, involving 429 previously untreated patients with metastatic disease, has been performed with doxorubicin (50 mg/m²) in combination with docetaxel (75 mg/m²) (AT arm) versus doxorubicin (60 mg/m²) in combination with cyclophosphamide (600 mg/m²) (AC arm).
Danish: Et stort randomiseret fase III-studie, med 429 tidligere ubehandlede patienter med metastatisk sygdom, er blevet udført med doxorubicin (50 mg/m2) i kombination med docetaxel (75 mg/m2) (AT arm) versus doxorubicin (60 mg/m2) i kombination med cyclofosfamid (600 mg/m2) (AC arm).
English: The ORR was 59.3% (95% CI: 52.8 - 65.9) in AT arm versus 46.5% (95% CI: 39.8 - 53.2) in AC arm.
Danish: Total responshyppighed var 59,3 % (95 % CI : 52,8 - 65,9) i AT armen i forhold til 46,5 % (95 % CI : 39,8 - 53,2) i AC armen.
English: Lacrimation increased
Danish: Øget lakrimation
English: What the solvent vial contains:
Danish: Hætteglas med solvens indeholder:
English: In study TAX316, 26 patients (3.5%) in the TAC arm and 17 patients (2.3%) in the FAC arm experienced congestive heart failure.
Danish: I studiet (TAX 316) oplevede 26 patienter (3,5 %) i TAC-armen og 17 patienter (2,3 %) i FAC-armen kongestivt hjertesvigt.
English: After 10 years of follow-up in GEICAM 9805 study, acute leukaemia occurred in 1 of 532 (0.2%) patients.
Danish: Efter 10 års opfølgning i GEICAM9805-studiet forekom akut leukæmi hos 1 ud af 532 (0,2%) patienter i TAC-armen.
English: 4.1.3 Inject the entire contents of the syringe into the corresponding Docetaxel Teva vial.
Danish: 4.1.3 Injicer hele indholdet fra sprøjten i det tilsvarende Docetaxel Teva-hætteglas.
English: 4.2.5 As with all parenteral products, Docetaxel Teva premix solution and infusion solution should be visually inspected prior to use, solutions containing a precipitate should be discarded.
Danish: 4.2.5 Som alle andre parenterale præparater bør Docetaxel Teva præmix-opløsning og infusionsvæske inspiceres visuelt inden brug, og opløsninger med udfældning skal kasseres.
English: Luxembourg/Luxemburg Teva Pharma Belgium N.V./S.A./AG Tél: +32 3 820 73 73
Danish: Teva Pharma Belgium N.V./S.A./AG Tél: +32 3 820 73 73
English: In non clinical studies, docetaxel has genotoxic effects and may alter male fertility (see section 5.3).
Danish: Docetaxel har vist genotoksiske virkninger i ikke-kliniske studier og kan ændre den mandlige fertiliteten hos hanner (se pkt.
English: In combination with cisplatin For patients who are dosed initially at docetaxel 75 mg/m2 in combination with cisplatin and whose nadir of platelet count during the previous course of therapy is <25,000 cells/mm3, or in patients who experience febrile neutropenia, or in patients with serious non-haematologic toxicities, the docetaxel dose in subsequent cycles should be reduced to 65 mg/m2.
Danish: Hos patienter med en initialdosis på 75 mg/m2 i kombination med cisplatin med en minimum blodpladeværdi under den tidligere behandlingsrunde på < 25000 celler/mm3 eller hos patienter, der får febril neutropeni eller hos patienter, med alvorlig, ikke-hæmatologisk toksicitet, bør docetaxeldosis reduceres til 65 mg/m2 i de følgende behandlingsrunder.
English: Docetaxel Teva is an antineoplastic agent and, as with other potentially toxic compounds, caution should be exercised when handling it and preparing Docetaxel solutions.
Danish: Docetaxel Teva er et antineoplastisk stof, og som med andre potentielle toksiske lægemidler, skal man udvise forsigtighed ved brug og fremstilling af Docetaxel Teva-opløsninger.